ADVANCED ACCELERATOR APPLICATIONS USA INC
Overview
ADVANCED ACCELERATOR APPLICATIONS USA INC is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering LUTETIUM [177 LU] TRICHLORIDE.
API / Drug Master Files
ADVANCED ACCELERATOR APPLICATIONS USA INC holds 1 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- LUTETIUM [177 LU] TRICHLORIDEActive2017-05-02
- LYSINE HYDROCHLORIDE (HCI)-ARGININE HYDROCHLORIDE (HCI), 2.5%, SOLUTIONInactive2016-09-26
- KIT FOR PREPARATION OF 99M TC-RHANNEXIN V-128Inactive2015-03-10
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to ADVANCED ACCELERATOR APPLICATIONS USA INC in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.